Skip to content
Login
Search:
CROI Conference
CROI ConferenceCROI Conference
  • About CROI
    • CROI 2027 Important Dates
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • CROI Abstract Categories
    • Abstract Guidelines and Submission
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Who Can Attend
    • Letter Of Invitation (For Visa And Other Purposes)
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
  • Program
    • CROI 2027 Program
    • Our Voices
    • Media
    • Embargo Policies And Press Release Policies
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • About CROI
    • CROI 2026 Preliminary Important Dates and Deadlines
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • Abstract Guidelines and Submission
    • CROI Abstract Categories
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Oral Abstract Presentation Guidelines
    • Poster Presentation Guidelines
    • Themed Discussion Guidelines
    • Plain Language Summaries: A Mile-High View at CROI 2026
    • People-First Language and the Use of Appropriate Terminology
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Registration
    • Who Can Attend
    • Media Accreditation and Registration
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
    • Scholarship Travel
  • Program
    • CROI 2027 Program
    • CROI 2026 Resources
    • Our Voices
    • Media
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • CROI 2027 Important Dates

Search Results for: node/PEP: Remember Me?

369 – Safety and PD-1 Receptor Occupancy Following Low-Dose Anti-PD1 in Adults With HIV

By Jimmy He PharmD, DScMarch 31, 2026

…dose). Fine needle aspirates aspirates (FNA) of a groin lymph node were collected before and 2 weeks after the infusion and regular blood sampling was performed over 24 weeks. The…

Visualizing the Early Events of Antigen Recognition by B Cells

By Enthusiast Inc MDFebruary 16, 2016

…initiated by the encounter with and acquisition of cognate antigen by the B cell receptor (BCR); processes occurring primarily in secondary lymph nodes (SLOs) such as the lymph node (LN)…

WHOLE-BODY PET IMAGING OF THE HIV RESERVOIR USING RADIOLABELED VRC01

By Jimmy He PharmD, DScApril 28, 2020

…lymphoid tissue (NALT), and bone marrow in viremic participants compared with uninfected controls (all P<0.05). SUVmax/mean (NALT, bone marrow) and SUVmean (inguinal lymph node) were significantly higher in ART-suppressed individuals…

Imaging the Spatial Distribution of Efavirenz in Intact HIV Tissue Reservoirs

By Enthusiast Inc MDFebruary 27, 2015

…reservoir tissues of a primate model using a novel approach to mass spectrometry imaging (MSI). Methods: Reservoir tissues (GALT, lymph nodes, brain, testes) were removed at necropsy from an uninfected…

Identifying Defective and Identical Viral Genomes in HIV Reservoirs During Effective HIV Therapy

By Enthusiast Inc MDSeptember 29, 2014

…a cause of persistence. Methodology: Using single-proviral sequencing we isolated intracellular HIV-1 genomes derived from defined subsets of CD4+ T cells (naive, central (CM)-, transitional (TM)-, and effector (EM)-memory) from…

EDITING OF SIV IN NONHUMAN PRIMATES BY CRISPR-CAS9 IN VIRAL RESERVOIRS

By Jimmy He PharmD, DScApril 28, 2020

…performed on lymph nodes in parallel to detect the AAV9-CRISPR-Cas9 viral vector and expression of the Cas9 gene. Broad excision of SIV proviral DNA was observed in lymph nodes and…

MACHINE LEARNING REVEALS T-CELL ACTIVATION PATHWAYS INDUCED BY INFLUENZA VACCINE

By Enthusiast Inc MDMarch 7, 2019

…central memory CXCR5mid node gave rise to a CXCR5hiCD32hi node that was unaffected by QIV and two vaccine-inducible activated ICOS+PD-1+CD38+CXCR3+CXCR5+CD32mid/hi nodes. Circulating CXCR5+CD4+ T-cells fall into three major related populations….

1116 – Impact of AIFA Reimbursement on the PrEP-Naive Population Characteristics and Incidence of STIs

By Jimmy He PharmD, DScApril 1, 2026

…and PEP use, PrEP regimen, retention, and vaccination status (HAV, HBV, HPV, Mpox) were collected. STI incidence was expressed as rates per 100 person-years (py). Chi-squared, Fisher’s exact and Student’s…

Specific Binding Characteristics of HLA Alleles Associate with Nevirapine Hypersensitivity

By Enthusiast Inc MDSeptember 29, 2014

…be shared between these alleles. Methodology: HLA-A,-B-,-C, -DR typing was performed on stored DNA from a retrospective case controlled analysis of NVP HSR (ClinicalTrials.gov NCT00310843) using the 454 FLX platform….

SIV ESCAPE FROM A VACCINE TARGETING CLEAVAGE SITES IS ASSOCIATED WITH A FITNESS LOSS

By Enthusiast Inc MDFebruary 16, 2017

…acquisition and disease progression after SIVmac239 challenge. We sequenced SIV populations isolated after challenge from vaccinees (n=12) immunized with a VSV vector expressing a 20-amino acid peptides overlapping each of…

←1
2345678910111213141516171819202122232425262728293031
…3233343536…
37383940414243444546474849505152535455565758596061626364656667686970717273747576777879808182
83→
Copyright © 2026 CROI Foundation/IAS-USA. All Rights Reserved.
Website by Enthusiast, Inc.
  • About CROI
  • Presenters
  • Abstracts
  • Scholarships
  • Program
Footer Menu
Go to Top